Welcome to Accord Medical Clinic Address Blk 325 Ubi Avenue 1 #01-701 Singapore
Accord Medical Clinic – Singapore
Menu
6844 1528
Call : 6844 1528
Menu
Medications
Danuglipron
An investigational oral GLP-1 weight-loss tablet in clinical trials, and how it may expand treatment options.
PLAIN ENGLISH
Patient-Friendly Explanation
Danuglipron is an investigational weight-loss medicine taken as a tablet that works like the GLP-1 hormones your gut releases after eating. It helps you feel full sooner and eat less. It is not yet available for prescription while clinical trials continue.
MEDICAL
Clinical Definition
Danuglipron is an oral, small-molecule GLP-1 receptor agonist in development for obesity and type 2 diabetes. Unlike injectable peptide GLP-1 agonists, it is absorbed orally and directly stimulates GLP-1 receptors, enhancing glucose-dependent insulin secretion and promoting satiety. Phase 2 trials showed dose-dependent weight loss; gastrointestinal tolerability and optimal once-daily dosing remain under investigation.
KEY INSIGHT
Why It Matters
An effective oral GLP-1 option would broaden non-injectable treatment choices for patients who prefer tablets. Dr Joseph Wang follows these emerging therapies to discuss future options alongside currently approved medications.
⚕️
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for medical concerns. Accord Medical Clinic Singapore is an MOH-registered medical clinic in Singapore. Dr Joseph Wang (Family Physician) provides medical weight management consultations.